Although we determined higher Raftlin levels in PsA patients than in controls (11.35 ± 9.82 vs 9.48 ± 9.61 ng/mL), the difference did not reach statistical significance.
← all excerpts
Raftlin - a potential biomarker for axial spondyloarthritis and psoriatic arthritis: An observational study.
1
—
—